Many Walk Fairfield Beach in Support of Ovarian Cancer Patients

The morning of Sunday, May 22, 2022 a group of Fairfield County neighbors went to Jennings Beach in Fairfield for a two mile round-trip walk to Penfield Reef in support of #OvarianCancer patients, survivors and caregivers at Clearity Foundation, which provides free programs and services including treatment decision support and counseling.

Three time #OvarianCancer survivor and Easton mom Noreen Forde organized her family, friends and fellow members from the Gaelic-American Club to form a local team for #TealRevolution to bring awareness to ovarian cancer. This walk was held as part of Clearity’s #TealRevolution to help women and their families in need of support during a difficult cancer diagnosis.

State Representative Cristin McCarthy Vahey of Fairfield presented Noreen Forde with a Proclamation from the State of Connecticut in support of her work with Clearity. Former Fairfield State Representative Brian Farnen also attended.

Ovarian cancer is a local and global concern and much more needs to be done to tackle this disease on all fronts as it is often overlooked and underfunded. Ovarian cancer is the most lethal of the female cancers for which there is no reliable screening test, and every woman is at risk. With delays in diagnoses due to this lack of screening and because symptoms are often confused with other less severe illness, most women are diagnosed once the cancer has already spread making it more difficult to treat. These women are our mothers, grandmothers, aunts, sisters, neighbors and friends.

This year in the United States

• Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system.
• A woman's risk of getting ovarian cancer during her lifetime is about 1 in 78.
• Her lifetime chance of dying from ovarian cancer is about 1 in 108.

In 2022 in Connecticut

• About 240 women will receive a new diagnosis of ovarian cancer.
• About 160 women will die from ovarian cancer.

For more information, contact: John Brannelly, jbrannelly@clearity.org or cell 619-405-3523